A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity
Open Access
- 1 April 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 93 (4), 759-768
- https://doi.org/10.1111/j.1476-5381.1988.tb11460.x
Abstract
1 The effects of vesamicol (2-(4-phenylpiperidino) cyclohexanol), an inhibitor of acetylcholine storage, and its two optical isomers have been studied on neuromuscular transmission in rat and frog muscle, and on nerve conduction in frog nerve. 2 Racemic vesamicol produced a pre-block augmentation of twitch tension that also occurred in directly-stimulated muscle. This effect is thus at least partially due to an increase in muscle contractility. 3 (—)-Vesamicol was approximately 20 times more potent than (+)-vesamicol in blocking twitches elicited at 1 Hz. This degree of stereoselectivity is similar to that measured for inhibition of acetylcholine uptake by isolated synaptic vesicles. Both enantiomers were equally weak in reducing nerve action potential amplitude in frog nerve. 4 Further studies with the active isomer, (—)-vesamicol, showed that, like that produced by racemic vesamicol, the neuromuscular block was highly frequency-dependent. The block was not reversed by choline or neostigmine, but was partially reversed by 4- or 3,4-aminopyridine. 5 Preliminary electrophysiological studies showed that vesamicol reduced miniature endplate potential amplitude in rapidly-stimulated frog nerve-muscle preparations. Addition of lanthanum ions increased the frequency of miniature endplate potentials and led to the appearance of apparently normal-sized potentials amongst those of reduced amplitude. 6 The results show the close agreement between pharmacological and biochemical observations indicating the suitability of the rat diaphragm as a test model for substances of this nature. The degree of reversibility of the vesamicol-induced neuromuscular block by aminopyridines was unexpected, and it is suggested that in the presence of a drug which greatly increases release, a pool of acetylcholine is capable of being released which is not normally releasable after block of storage by vesamicol. It is also considered possible that the results from the intracellular recording studies may be explained in these terms.This publication has 21 references indexed in Scilit:
- The vesicular acetylcholine transport systemTrends in Neurosciences, 1987
- Reduction of quantal size by vesamicol (AH5183), an inhibitor of vesicular acetylcholine storageBrain Research, 1986
- Acetylcholine Synthesis and Release by a Sympathetic Ganglion in the Presence of 2‐(4‐Phenylpiperidino) Cyclohexanol (AH5183)Journal of Neurochemistry, 1986
- Estimates of quantal content during 'chemical potentiation' of transmitter releaseProceedings of the Royal Society of London. B. Biological Sciences, 1979
- Effects of 4-aminopyridine on neuromuscular transmissionBrain Research, 1978
- Effect of lanthanum ions on function and structure of frog neuromuscular junctionsProceedings of the Royal Society of London. B. Biological Sciences, 1971
- Influence of lanthanum on transmitter release at the neuromuscular junctionJournal of Neurobiology, 1971
- The neuromuscular blocking action of 2-(4-phenylpiperidino) cyclohexanol (AH 5183)European Journal of Pharmacology, 1969
- The Effect of Calcium on the Desensitization of Membrane Receptors at the Neuromuscular JunctionThe Journal of general physiology, 1966
- ACETYLCHOLINE METABOLISM OF A SYMPATHETIC GANGLIONCanadian Journal of Biochemistry and Physiology, 1961